686 related articles for article (PubMed ID: 33287221)
1. Targeting the pH Paradigm at the Bedside: A Practical Approach.
Koltai T
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287221
[TBL] [Abstract][Full Text] [Related]
2. The Ph paradigm in cancer.
Koltai T
Eur J Clin Nutr; 2020 Aug; 74(Suppl 1):14-19. PubMed ID: 32873952
[TBL] [Abstract][Full Text] [Related]
3. Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research.
Harguindey S; Arranz JL; Polo Orozco JD; Rauch C; Fais S; Cardone RA; Reshkin SJ
J Transl Med; 2013 Nov; 11():282. PubMed ID: 24195657
[TBL] [Abstract][Full Text] [Related]
4. Proton channels and exchangers in cancer.
Spugnini EP; Sonveaux P; Stock C; Perez-Sayans M; De Milito A; Avnet S; Garcìa AG; Harguindey S; Fais S
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2715-26. PubMed ID: 25449995
[TBL] [Abstract][Full Text] [Related]
5. Na+-H+ exchanger, pH regulation and cancer.
Reshkin SJ; Cardone RA; Harguindey S
Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):85-99. PubMed ID: 22738122
[TBL] [Abstract][Full Text] [Related]
6. Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H
Harguindey S; Alfarouk K; Polo Orozco J; Fais S; Devesa J
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050492
[TBL] [Abstract][Full Text] [Related]
7. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine.
Bashraheel SS; Domling A; Goda SK
Biomed Pharmacother; 2020 May; 125():110009. PubMed ID: 32106381
[TBL] [Abstract][Full Text] [Related]
8. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy.
Izumi H; Torigoe T; Ishiguchi H; Uramoto H; Yoshida Y; Tanabe M; Ise T; Murakami T; Yoshida T; Nomoto M; Kohno K
Cancer Treat Rev; 2003 Dec; 29(6):541-9. PubMed ID: 14585264
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies.
Harguindey S; Polo Orozco J; Alfarouk KO; Devesa J
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480530
[TBL] [Abstract][Full Text] [Related]
10. Na(+)/H(+) antiporter (NHE1) and lactate/H(+) symporters (MCTs) in pH homeostasis and cancer metabolism.
Counillon L; Bouret Y; Marchiq I; Pouysségur J
Biochim Biophys Acta; 2016 Oct; 1863(10):2465-80. PubMed ID: 26944480
[TBL] [Abstract][Full Text] [Related]
11. Value of pH regulators in the diagnosis, prognosis and treatment of cancer.
Granja S; Tavares-Valente D; Queirós O; Baltazar F
Semin Cancer Biol; 2017 Apr; 43():17-34. PubMed ID: 28065864
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. A rationale for the use of proton pump inhibitors as antineoplastic agents.
De Milito A; Marino ML; Fais S
Curr Pharm Des; 2012; 18(10):1395-406. PubMed ID: 22360553
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-Induced Sarcopenia.
Bozzetti F
Curr Treat Options Oncol; 2020 Jan; 21(1):7. PubMed ID: 32002684
[TBL] [Abstract][Full Text] [Related]
15. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
16. pH Gradient Reversal: An Emerging Hallmark of Cancers.
Sharma M; Astekar M; Soi S; Manjunatha BS; Shetty DC; Radhakrishnan R
Recent Pat Anticancer Drug Discov; 2015; 10(3):244-58. PubMed ID: 26152150
[TBL] [Abstract][Full Text] [Related]
17. Voltage gated sodium channels in cancer and their potential mechanisms of action.
Angus M; Ruben P
Channels (Austin); 2019 Dec; 13(1):400-409. PubMed ID: 31510893
[TBL] [Abstract][Full Text] [Related]
18. pH gradient reversal fuels cancer progression.
Zheng T; Jäättelä M; Liu B
Int J Biochem Cell Biol; 2020 Aug; 125():105796. PubMed ID: 32593663
[TBL] [Abstract][Full Text] [Related]
19. Voltage-gated sodium channels and metastatic disease.
Brackenbury WJ
Channels (Austin); 2012; 6(5):352-61. PubMed ID: 22992466
[TBL] [Abstract][Full Text] [Related]
20. Intracellular calcium oscillations in strongly metastatic human breast and prostate cancer cells: control by voltage-gated sodium channel activity.
Rizaner N; Onkal R; Fraser SP; Pristerá A; Okuse K; Djamgoz MB
Eur Biophys J; 2016 Oct; 45(7):735-748. PubMed ID: 27665102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
